DK111142B - Fremgangsmåde til fremstilling af 3-(2'-chlorethoxy)-6-formyl-3,5-pregnadien-20-oner. - Google Patents
Fremgangsmåde til fremstilling af 3-(2'-chlorethoxy)-6-formyl-3,5-pregnadien-20-oner.Info
- Publication number
- DK111142B DK111142B DK161764AA DK161764A DK111142B DK 111142 B DK111142 B DK 111142B DK 161764A A DK161764A A DK 161764AA DK 161764 A DK161764 A DK 161764A DK 111142 B DK111142 B DK 111142B
- Authority
- DK
- Denmark
- Prior art keywords
- pregnadien
- chloroethoxy
- formyl
- ones
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- E—FIXED CONSTRUCTIONS
- E05—LOCKS; KEYS; WINDOW OR DOOR FITTINGS; SAFES
- E05D—HINGES OR SUSPENSION DEVICES FOR DOORS, WINDOWS OR WINGS
- E05D11/00—Additional features or accessories of hinges
- E05D11/10—Devices for preventing movement between relatively-movable hinge parts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mechanical Engineering (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT676363 | 1963-04-03 | ||
IT2011663 | 1963-10-01 | ||
IT2386663 | 1963-11-22 | ||
IT1541864A IT1051717B (it) | 1964-07-15 | 1964-07-15 | Perfezionamenti relativi a composti steroidi |
Publications (1)
Publication Number | Publication Date |
---|---|
DK111142B true DK111142B (da) | 1968-06-17 |
Family
ID=27452692
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK161764AA DK111142B (da) | 1963-04-03 | 1964-04-01 | Fremgangsmåde til fremstilling af 3-(2'-chlorethoxy)-6-formyl-3,5-pregnadien-20-oner. |
DK357565AA DK117421B (da) | 1963-04-03 | 1965-07-13 | Analogifremgangsmåde til fremstilling af 3-(ω-halogenalkoxy)-6-formyl- Δ<3,5>-pregnadien-20-oner. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK357565AA DK117421B (da) | 1963-04-03 | 1965-07-13 | Analogifremgangsmåde til fremstilling af 3-(ω-halogenalkoxy)-6-formyl- Δ<3,5>-pregnadien-20-oner. |
Country Status (10)
Country | Link |
---|---|
US (1) | US3314945A (fr) |
BE (2) | BE646036A (fr) |
BR (2) | BR6457948D0 (fr) |
CH (2) | CH463498A (fr) |
DE (2) | DE1235314B (fr) |
DK (2) | DK111142B (fr) |
FR (2) | FR3330M (fr) |
GB (2) | GB1001215A (fr) |
NL (4) | NL6403177A (fr) |
SE (1) | SE342037B (fr) |
-
0
- NL NL129875D patent/NL129875C/xx active
- NL NL127421D patent/NL127421C/xx active
- FR FR155D patent/FR155F/fr active Active
-
1964
- 1964-03-25 NL NL6403177A patent/NL6403177A/xx unknown
- 1964-03-30 BR BR157948/64A patent/BR6457948D0/pt unknown
- 1964-03-31 GB GB13147/64A patent/GB1001215A/en not_active Expired
- 1964-03-31 CH CH404364A patent/CH463498A/de unknown
- 1964-03-31 DE DES90310A patent/DE1235314B/de active Granted
- 1964-04-01 DK DK161764AA patent/DK111142B/da unknown
- 1964-04-01 FR FR969348A patent/FR3330M/fr active Active
- 1964-04-02 BE BE646036D patent/BE646036A/xx unknown
-
1965
- 1965-07-01 NL NL6508458A patent/NL6508458A/xx unknown
- 1965-07-08 DE DE19651493072 patent/DE1493072A1/de active Pending
- 1965-07-09 GB GB29178/65A patent/GB1059603A/en not_active Expired
- 1965-07-12 CH CH971065A patent/CH485695A/de not_active IP Right Cessation
- 1965-07-12 US US471450A patent/US3314945A/en not_active Expired - Lifetime
- 1965-07-13 BR BR171246/65A patent/BR6571246D0/pt unknown
- 1965-07-13 DK DK357565AA patent/DK117421B/da unknown
- 1965-07-14 BE BE666853D patent/BE666853A/xx unknown
- 1965-07-14 SE SE9274/65A patent/SE342037B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB1001215A (en) | 1965-08-11 |
NL6403177A (fr) | 1964-10-05 |
NL129875C (fr) | |
CH463498A (de) | 1968-10-15 |
BE646036A (fr) | 1964-07-31 |
FR155F (fr) | |
BR6571246D0 (pt) | 1973-09-06 |
BR6457948D0 (pt) | 1973-07-17 |
NL127421C (fr) | |
US3314945A (en) | 1967-04-18 |
DE1493072A1 (fr) | 1971-11-04 |
DE1235314C2 (fr) | 1967-09-14 |
FR3330M (fr) | 1965-05-24 |
GB1059603A (en) | 1967-02-22 |
DK117421B (da) | 1970-04-27 |
SE342037B (fr) | 1972-01-24 |
CH485695A (de) | 1970-02-15 |
BE666853A (fr) | 1965-11-03 |
NL6508458A (fr) | 1966-01-17 |
DE1235314B (de) | 1967-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK106552C (da) | Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner. | |
DK125553B (da) | Fremgangsmåde til fremstilling af substituerede 2,4-diamino-5-benzylpyrimidiner. | |
DK120546B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner. | |
DK109088C (da) | Fremgangsmåde til fremstilling af 1,2,4-oxadiazolderivater. | |
DK117957B (da) | Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener. | |
DK112523B (da) | Fremgangsmåde til fremstilling af 2,3-pyridindiol. | |
DK106185C (da) | Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner. | |
DK119107B (da) | Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener. | |
DK116656B (da) | Analogifremgangsmåde til fremstilling af 11-oxygenerede 3-(2'-chlorethylthio)-6-formyl-9α-fluor-3,5-pregnadien-20-oner. | |
DK121757B (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10,11-dihydroxy-5-(3-substituerede aminopropyliden)-5H-dibenzo-[a,d]-cycloheptenforbindelser. | |
DK108004C (da) | Fremgangsmåde til fremstilling af 2,6-dichlorbenzonitril. | |
DK105471C (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepin-3H-forbindelser. | |
DK114273B (da) | Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler. | |
DK115184B (da) | Fremgangsmåde til fremstilling af 6,7-benzomorphaner. | |
DK106329C (da) | Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien. | |
DK114962B (da) | Fremgangsmåde til fremstilling af α, α, α', α'-tetramethyl-xylylen-dicarbinoler. | |
DK112031B (da) | Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien. | |
DK116594B (da) | Fremgangsmåde til fremstilling af 4,1,5-benzoxadiazociner. | |
DK109895C (da) | Fremgangsmåde til fremstilling af 1,3-dioxo-2-alkyl-cyclopentaner. | |
DK114904B (da) | Fremgangsmåde til fremstilling af 3,5-diiodthyroniner. | |
DK113917B (da) | Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon. | |
DK111142B (da) | Fremgangsmåde til fremstilling af 3-(2'-chlorethoxy)-6-formyl-3,5-pregnadien-20-oner. | |
DK111175B (da) | Fremgangsmåde til fremstilling af 4',19-diacylcymaroler. | |
DK103081C (da) | Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner. | |
DK115852B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin. |